血液静止和补充在全源造血干细胞移植:两个互动系统的临床意义
Dimitrios A Tsakiris1,2, Eleni Gavriilaki3, Ioanna Chanou4
1University of Basel, Basel, Switzerland. dimitrios.tsakiris@unibas.ch.
Bone marrow transplantation
|July 14, 2024
概括
造血干细胞移植 (HCT) 的并发症涉及血液静止和补充系统之间的相互作用. 了解这些相互作用是管理严重的移植后疾病的关键,如HSCT-TMA,SOS/VOD和GVHD.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 血管生物学 血管生物学
背景情况:
- 造血干细胞移植 (HCT) 为血液病提供治疗潜力.
- HCT后的早期和晚期并发症是由于条件,移植对宿主疾病 (GVHD) 和免疫复合延迟引起的.
- 血液静止和补充系统是关键的调节性防御机制,与HCT并发症有关.
研究的目的:
- 审查当前关于血液静止和补充系统变化的知识,在异构HCT之后.
- 在HCT并发症的背景下探索血液静止和补充之间的相互作用.
- 阐明这些系统变化如何影响HCT后的临床结果.
主要方法:
- 对研究血液静止和补充途径的文献综述后异构HCT.
- 分析共享的分子点,特别是内皮,在血液静止和补充之间.
- 观察到的静血和补体变化的相关性与特定的临床并发症.
主要成果:
- 血静和补充系统都在异性HCT后表现出显著的变化.
- 这些系统之间的相互作用有助于移植相关的血栓性微血管病变 (HSCT-TMA),鼻腔阻塞综合征/静脉闭塞性疾病 (SOS/VOD) 和GVHD的发病.
- 像内皮质这样的共同目标对于调解这些复杂的相互作用至关重要.
结论:
- 血液静止和补充的变化是主要HCT并发症的病理生理学的组成部分.
- 了解这些系统之间的相互作用对于预测和潜在地减轻HCT后不良临床事件至关重要.
- 针对这些相互作用的进一步研究可能为HCT接受者提供新的治疗策略.
相关概念视频
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Bone Marrow Sampling and Transplants
323
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
323
Tissue Transplantation
354
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
354
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Hematopoiesis
5.2K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.2K


